The founder and ex-CEO of Papa John's International Inc. has responded to his wife's divorce filing. John Schnatter, who has been married to Annette (Cox) Schnatter since 1987, admits to all of the facts about the couple's marriage as detailed in the petition for a dissolution of marriage, according to an Oldham County family court filing. The document also states that he and Annette have reached a separation agreement.
Keep your money close when Wall Street and surging stock prices tempt you to buy, writes Michael Sincere.
Close-out retailer Big Lots said it swung to a third-quarter ending Nov. 2 net profit of $127 million, or $3.25 a share, as sales edged up 1.6% to $1.17 billion and comparable-store sales slipped 0.1%. Excluding gains including the sale of a California distribution center, it would have lost 18 cents a share. Analysts polled by FactSet expected a 16 cents a share loss on sales of $1.16 billion. Big Lots says it expects fourth-quarter profit of $2.40 to $2.55 a share and a slight rise in comparable-store sales. Analysts had seen fourth-quarter earnings of $2.68 a share. Big Lots says it expects a return to EPS and EBIT growth in 2020.
UPGRADE Dear Catey, I’m a single, 56-year-old female. I’m currently unemployed and am going to sell my house. I will walk away with at least $100,000. This is all the money I have at the moment. I will be looking for work (I was laid off).
Amazon’s promise of one-day shipping has led it to increasingly rely on its own air cargo division, Amazon Air. The pilots don’t work for Amazon directly, but are employed by the contractors Air Transport Services Group (ATSG) and Atlas Air. More than 200 cargo pilots who fly for ABX Air, which is a division of ATSG, cast a vote of “no confidence” against management’s ability to resolve ongoing labor disputes, reported Reuters earlier this week.
(Bloomberg) -- Investors face a crush of events next week that could sweep away the biggest hurdles to a full-blown race into riskier assets, if things line up just right.Over the second half of the week, possible catalysts for a Treasury market sell-off will arrive in close succession: Policy decisions from the U.S. and euro-zone central banks are expected to offer no fresh hints of easing in the cards, and the U.K. election could finally pave a more resolute course for an exit from the European Union.Treasuries were already on the ropes Friday, thanks to a U.S. payrolls report that surpassed analysts’ expectations. That pushed the S&P 500 to the brink of a record high, drove market pricing for a full Federal Reserve rate cut to the end of 2020, and thrust the 10-year yield toward the upper end of its recent range, at around 1.84%.The events ahead will determine the macroeconomic backdrop heading into the new year, but the question for investors is how much of the real action next week is already baked in. For Kathy Jones at Charles Schwab & Co., the more pressing issue remains U.S.-China trade talks. The big catalyst for risk appetite and significantly higher yields in one of the last actively traded weeks of the year would be a credible signal that the U.S. will forgo the additional tariffs it’s threatening to impose on Chinese goods on Dec. 15, she said.“We do have a confluence of things next week and there’s a good likelihood that yields will rise -- but will they just rip higher?” said Jones, chief fixed-income strategist at Charles Schwab. “You’d need some really surprisingly good news on the trade war.”Global growth headwinds from trade friction have helped pull benchmark U.S. 10-year yields down about 80 basis points in 2019, driving Treasuries to a 7.3% return this year through Dec. 5. It’s shaping up to be the best annual performance since 2011.Some SwayAnd in Jones’s view, economic numbers could still have sway.Treasuries could take a hit ahead of the week’s high-profile events if the consumer price index reading due Dec. 11, the same day as the Fed decision, shows an annual increase faster than the expected 2%. That could unsettle the widely held view that inflation pressures are nowhere near strong enough to fit the Fed’s stated criteria for a rate hike. But there’s also potential for yields to fall should the Dec. 13 retail sales figures counter the market’s conviction that the U.S. consumer is holding up.While the data may fall short of alarming the Fed’s inflation hawks, it’s clear from Chairman Jerome Powell’s recent statements that his view of the economy is biased toward optimism -- as a glass “more than half full.”There hasn’t been much in comments from Fed speakers to suggest they’ve downgraded projections for interest rates -- which will be updated Wednesday -- since September. At the time, the “dot plot” of policy makers’ views suggested that the majority see the next move as a hike rather than a cut, and most expect rates to remain on hold or move higher in 2020.Whichever way traders see the risks tilting through year-end, the coming week could be one of the last good opportunities of the decade to jump into the fray, before clearing out for the holidays.What to WatchMuch of the potentially market-moving action in the week ahead is offshore, with the European Central Bank’s decision and the U.K. election. But markets will also be looking for signs of movement in trade talks ahead of the Dec. 15 U.S. tariff deadlineThe FOMC’s meeting tops the domestic agenda:Dec. 11: FOMC rate decision and Powell press conferenceDec. 13: New York Fed’s John Williams discusses topics in monetary policyHere’s the economic calendar:Dec. 10: NFIB small business optimism; nonfarm productivity; unit labor costsDec. 11: MBA mortgage applications; consumer price index; real average earnings; monthly budget statementDec. 12: Producer price index; jobless claims; Bloomberg consumer comfort; household change in net worthDec. 13: Import/export prices; retail sales; Bloomberg U.S. economic survey; business inventoriesAnd the auction schedule:Dec. 9: $42 billion of 13-week bills; $36 billion of 26-week bills; $38 billion 3-year notesDec. 10: $24 billion of 10-year notesDec. 12: 4-, 8-week bills; 30-year bond re-openingTo contact the reporter on this story: Emily Barrett in New York at email@example.comTo contact the editors responsible for this story: Benjamin Purvis at firstname.lastname@example.org, Mark Tannenbaum, Nick BakerFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
Dec.05 -- Sylvia Jablonski, managing director of capital markets at Direxion, discusses the OPEC meeting, oil markets and her outlook for commodities. She speaks on “Bloomberg Markets: China Open.”
Ever since rapidly growing Chinese coffee retailer Luckin Coffee (NASDAQ:LK) hit the public markets at an IPO price of $17 per share in May 2019, I've been pounding on the table, calling LK stock a long-term winner with tremendous upside potential.Source: Keitma / Shutterstock.com Today, LK stock trades hands at about $29. That represents a 70%-plus rally from its mid-May IPO price. For comparison purposes, the S&P 500 index is up less than 10% over that same stretch.In other words, Luckin Coffee stock has been a big winner so far. But, has all the winning been done? Is it too late to buy this strong stock?InvestorPlace - Stock Market News, Stock Advice & Trading TipsNo. Far from it. LK stock will continue to run materially higher over the next several years, powered by robust revenue and profit growth, the likes of which still isn't fully priced into shares today. Indeed, I think the long-term fundamentals here support LK stock at price tags above $40 in 2020. Luckin Coffee is a Long-Term WinnerThe bull thesis on LK stock is simple, compelling, and won't get cold anytime soon.China's nascent retail coffee market is booming. But, that retail coffee market is still small. The country's per capita coffee consumption measures around five cups per year. In America, per capita coffee consumption is up around 400 cups per year. In Norway and Sweden, people drink more than 1,000 cups per year. This huge discrepancy implies a huge opportunity for China's retail coffee market to expand over the next several years. * 7 Stocks to Buy in December Luckin Coffee is at the epicenter of this expanding Chinese retail coffee market. They operate small retail coffee shops that are designed for consumers to order their drinks ahead of time on their phones, and simply pick-up their coffee in the store a few minutes later. It's a unique concept which is attracting a lot of Chinese consumers because it optimizes convenience.Further, because these stores are doing really well, Luckin is opening a bunch of them. At the start of 2018, Luckin operated less than a dozen coffee shops. Today, they operate nearly 3,700, up 210% year-over-year.At 3,700 stores, Luckin is far from being done growing. Starbucks (NASDAQ:SBUX) operates more than 15,000 stores in the U.S. That's about 45 latte-locations for every million people. If Luckin were to match that rate, the company could be looking at more than 60,000 coffee shops in China.No, Luckin won't ever operate more than 60,000 stores in China. But, the point here is that robust unit growth will persist for a lot longer. As will its robust transaction-per-store growth. And average ticket size growth. Sustained big growth across all of those verticals will drive sustained big revenue growth. At the same time, margins are steadily improving, and Starbucks operates at 15%-20% operating margins, implying that Luckin has a huge opportunity to go from small and unprofitable today, to huge and profitable in five years.That transition will ultimately power LK stock well above $30 in the long run. Luckin Stock can Run Above $40Luckin Coffee's long-term profit growth prospects support LK stock at price tags north of $40 in 2020.The numbers here aren't too hard to follow. On the revenue side, there are three big drivers.For one, consider unit growth. Luckin is opening a ton of stores, and will continue to open a ton of stores because they are still small and the untapped addressable market is huge. This company should therefore be supported by 20%-plus unit growth over the next several years.Second, look at transactions-per-store growth. More and more customers will flock to those stores, because Luckin's mobile-focused ordering model is designed for the modern, urban consumer. Transactions per store were up more than 50% year-over-year last quarter. This metric should keep growing at a 10%-plus rate.Third, there's ticket size growth. The average ticket at Luckin remains very small, at under $2. Last quarter, average ticket increased more than 10%. It will continue to rise at a 10%-plus clip, as Luckin hikes prices and broadens its menu.Net net, Luckin projects as a 20%-plus unit grower, with 10%-plus transactions per store growth and 10%-plus average ticket growth. Putting all that together, Luckin reasonably projects as a 50%-plus revenue grower. Reasonably speaking, then, Luckin could be looking at $8 to $10 billion in revenues by 2025. * 7 Exciting Biotech Stocks to Buy Now Taking the mid-point and assuming operating margins progress towards industry-average 15-17% levels, then Luckin could produce around $4 in earnings per share by 2025. Based on a market-average 16x forward earnings multiple and a 10% discount rate, that equates to a 2020 price target for LK stock of nearly $44. Bottom Line on LK StockLK stock is a long-term winner that is in the early stages of its multi-year growth narrative. As this story plays out over the next few years, Luckin's revenue will march significantly higher, margins will improve by a ton, and today's big losses will turn into big profits.All of these positive developments will drive Luckin Coffee stock materially higher in the long run. At some point, valuation will become a problem. But, at $30, valuation isn't a problem yet, so the best thing to do here is remain long and strong.As of this writing, Luke Lango was long LK. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping * 6 Manufacturing Stocks to Buy as the Economy Recovers * The 7 Best Cryptocurrencies to Buy as Blockchain Heats Up The post Here's Why Luckin Coffee Stock is a Great Growth Stock to Buy Now appeared first on InvestorPlace.
It's been three weeks since the U.S. Food and Drug Administration recommended that Amarin's (NASDAQ:AMRN) prescription-strength fish oil drug, Vascepa, be approved for broader use to help patients at risk for heart and stroke problems. Amarin stock jumped on the news but has since fallen back into the low $20s. Source: Pavel Kapysh / Shutterstock.com The word on the street is that some of the biggest players in pharmaceuticals are sniffing around Amarin's business. Some speculate that the Amarin stock price could be worth as much as $56 a share in the hands of a strategic buyer.With M&A heating up in the biotech industry, could Amarin be worth $20 billion to a strategic buyer?InvestorPlace - Stock Market News, Stock Advice & Trading TipsAmarin is currently valued at $7.8 billion by investors. A $20-billion buy would mean paying a 160% premium to its current stock price. Maybe I'm old fashioned, but that strikes me as just a little too rich for a drug that's only been approved for sale since July 2012 and then only to lower patients' triglyceride levels. Are investors getting a little ahead of themselves? A Closer Look at Amarin StockAmarin released its Q3 2019 earnings in early November. Revenues grew 103% to $112.4 million. Through the first nine months, business was so good it exceeded company sales for all of 2018. * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping As for Vascepa, Amarin reported that the total number of prescriptions at the end of September was 826,000 at the midpoint of estimates from third-party healthcare data providers, up 89% from the same period a year earlier. "Growth in net product revenue was supported by increased prescription levels of Vascepa® (icosapent ethyl) capsules. The increased prescription levels reflect both a higher number of Vascepa prescribers and an increase in the average prescriptions per prescriber," stated the Q3 2019 press release. Not bad for a drug that's limited to treating patients with high triglycerides. Imagine what it could do with a broader application to lower fat levels for a significant number of Americans at risk for heart problems. Currently, these people are using drugs such as Lipitor and Zocor to lower their cholesterol. The FDA believes Vascepa can reduce the number of people with heart problems. It's expected to make a final decision by Dec. 28. The recent findings by the regulatory body suggest Amarin will receive good news by the end of this month."There is no doubt this drug could benefit a substantial portion of the U.S. population and meet an unmet need," said Dr. Jack Yanovski, a panelist and hormone specialist from the federal National Institutes of Health.Some analysts expect Vascepa to deliver annual sales as high as $3 billion.While it wouldn't be good enough to make 2018's list of the top-selling drugs, it's important to note that most of the drugs on this list are related to cancer or arthritis. As far as I can tell, there is only one cardiovascular drug, Xarelto, that's on the list. So, the interest level from Big Pharma should be high. Is Amarin Stock Worth $56?Let's assume that Vascepa hits the analyst target of $3 billion. Amarin currently has $286.5 million in revenue through the first nine months of the fiscal year. In Q4 2018, it had revenues of $77.3 million. Double that in 2019, and you get full-year sales of $440.1 million, 92% higher than in 2018.So, we're talking about a seven-fold increase in Amarin's sales from the broader use of Vascepa. Amarin is trading at 19.7 times sales. If it gets to $3 billion and maintains the same multiple, it would have a future market cap of close to $60 billion. The question then becomes how long it will take to get to $3 billion. It's currently growing revenues at 50% for a drug that's used for just one application. The potential user base to lower fat levels is so much higher. While some other company may develop a drug that puts Vascepa on the sidelines, it's hard to imagine that happening in the next 12-24 months. In the meantime, Amarin gets a big headstart on its competition. That alone could have the Pfizer's (NYSE:PFE) of the world come calling. I think it could be worth $20 billion to a strategic buyer. In 2020, we might find out who that is. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping * 6 Manufacturing Stocks to Buy as the Economy Recovers * The 7 Best Cryptocurrencies to Buy as Blockchain Heats Up The post Acquisition Rumors Aren't the Only Thing Moving Amarin Stock appeared first on InvestorPlace.
Senior-citizen bankruptcies are on the rise, driven by socioeconomic factors such as shrinking Social Security payments, higher health-care costs, and increased individual responsibility for retirement savings. But there are some things you can do to make for a smoother stay in bankruptcy.
Warren Buffett, Carl Icahn, Jerry Jones and Sam Zell are just a few of the bargain-hunters flocking to the energy industry — the worst-performing sector of 2019. The miserable year caps a grim decade, which has brought the oil and gas sector’s weighting in the S&P 500’s market capitalisation to a record-low 4 per cent. That is down dramatically from the 13 per cent weighting of 2008, when oil was trading above $140 a barrel and the world was much less determined to wean itself off fossil fuels. In 2011 the energy sector was trading at about the same level as the broader market, as a multiple of book value.
Since becoming General Electric (NYSE:GE) CEO in October 2018, Larry Culp has made the company a favorite of turnaround lovers.Source: Sergey Kohl / Shutterstock.com If you picked up some shares one year ago, you're sitting on a gain of 54%. But it's all a matter of timing. If you bought the day Culp joined, you're still down 14%.The glory days of Jeff Immelt, when this was a $30 stock and a dividend aristocrat, are gone forever. Culp has frozen pensions, leading to talk of a general "pension crisis" sweeping the world.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut Culp has also remade his executive team, made hard decisions on what to keep and let new hires make forward-looking statements.From here, everything depends on execution. Hard DecisionsCulp's hardest decision may have been to let General Electric's biopharma unit go to his former employer, Danaher (NYSE:DHR). The cash is desperately needed to firm up the balance sheet, which still had $76 billion of debt on it, against a market capitalization of $94 billion, in September. * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping As I wrote in July, those numbers understate the case. The company also has $74 billion of "other liabilities" -- pensions and risks from old long-term care policies -- to deal with.The pension freeze helps with the former. The latter is a 25-year old legacy from former CEO Jack Welch, who took on re-insurance for long-term care policies before the cost of nursing care became apparent. Activists want Welch to turn in his retirement payout, as well as Immelt, whom I consider the greatest destroyer of shareholder value the world has ever known. It ain't happening. The New ToneThese moves have created a new tone around the company. Product rollouts are now called victories and buzzwords like "citizen developer" are gaining traction.Some analysts are coming around. Home Depot (NYSE:HD) co-founder Ken Langone says he likes General Electric again, saying Culp "is doing a hell of a job."But this is only tone. General Electric under Culp remains much as it was under Immelt and his successor, John Flannery, an industrial machine company. GE Power remains a drag on results, although the company now makes more from renewable energy equipment like wind turbines. Healthcare is mostly big machines. Boeing (NYSE:BA) remains a drag on GE Aviation, and GE Capital can no longer soften the blows.For the third quarter, General Electric reported a loss of nearly $6 billion, 69 cents per share, on revenues of $23.4 billion. Culp emphasized that losses from continuing operations were just 8 cents per share. He showed $650 million in industrial free cash flow. He also pointed to a backlog of orders that now totals $386 billion, mostly for jet engines and industrial turbines. Since then the shares are up 9%, against a 2.5% gain for the average S&P 500 stock.Not everyone is convinced. JPMorgan Chase (NYSE:JPM) analyst Stephen Tusa, who saw the Immelt disaster coming and may wear the label "GE Bear" to his grave, says General Electric is still missing targets set only in March. He believes numbers look good only because of restructured spending. The Bottom Line on General ElectricGeneral Electric remains an industrial goods company. Industrial goods are not a great business to be in. The company continues to struggle with enormous debt. The amount it will owe on those long-term care policies remains uncertain.I continue to wish Culp well, but from the sidelines. General Electric is, at best, a speculation. If you buy shares today, you're betting it can generate big profits from industrial revenue, and that it can grow. Hope is still not a plan.Dana Blankenhorn is a financial and technology journalist. His latest book is Technology's Big Bang: Yesterday, Today and Tomorrow with Moore's Law, essays on technology available at the Amazon Kindle store. Write him at email@example.com or follow him on Twitter at @danablankenhorn. As of this writing he owned shares in JPM. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping * 6 Manufacturing Stocks to Buy as the Economy Recovers * The 7 Best Cryptocurrencies to Buy as Blockchain Heats Up The post Larry Culp's General Electric Depends on Restructuring Plan appeared first on InvestorPlace.
Steven Gidumal, managing partner of Virtus Capital, says the fate of this relentless bull market hangs on what happens in the upcoming 2020 presidential election.
Dec.06 -- Isaac Poole, chief investment officer at Oreana Financial Services, discusses his outlook for oil in 2020 and his outlook for the global economy and for a recession. He speaks on “Bloomberg Markets: Asia.”
(Bloomberg) -- President Donald Trump added to the criticism of the World Bank’s plan for low-interest loans to China.“Why is the World Bank loaning money to China?” Trump said in a Twitter post on Friday night. “Can this be possible? China has plenty of money, and if they don’t, they create it. STOP!”His tweet came a day after Treasury Secretary Steven Mnuchin, at a congressional hearing, said that the administration opposes the plan by the bank, which has loaned more than $1 billion to China this year.The World Bank is expected to soon release its latest Country Partnership Framework document for China, which lays out its lending plans to the world’s second-largest economy. Mnuchin told the House Financial Services Committee on Thursday that China should be removed from the World Bank’s loan program.“The Treasury Department has negotiated significant reductions on China lending by the World Bank,” Mnuchin said.Several lawmakers voiced concerns about what they described as unannounced World Bank plans to continue lending to China despite rapid growth in the country’s per capita income. Mnuchin said the Treasury Department on Wednesday had filed an objection to the World Bank’s latest plans.Mnuchin advised Trump to recommend former Treasury official and Trump campaign adviser David Malpass to take charge of the bank earlier this year.The U.S. is the largest contributor to the World Bank, which provides low-interest loans to low-income nations.World Bank lending to China declined to $1.3 billion in fiscal year 2019 from $2.4 billion in fiscal 2017.A statement from the bank late Friday night said that lending to China “has fallen sharply and will continue to reduce as part of our agreement with all our shareholders including the United States. We eliminate lending as countries get richer.” To contact the reporters on this story: Saleha Mohsin in Washington at firstname.lastname@example.org;John Harney in Washington at email@example.comTo contact the editor responsible for this story: Kevin Whitelaw at firstname.lastname@example.orgFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
When most people go looking for a dividend stock, they tend to gravitate to the same old blue-chip stocks. There's good reason since many of these giants have large institutional investors behind them and a rich history of distributions to shareholders that can date back more than a century. Stocks like flailing industrial giant General Electric Co. (ticker: GE) and fallen utility PG&E Corp. (PCG) prove that even big stocks can carry big risks.
It's time to look forward to 2020. And analysts are already forecasting which will be the most profitable S&P; 500 companies in the new year.
Companies from financial services to real estate and medical devices offered investors holiday cheer, disclosing plans to increase their dividends this past week.
In my experience as a money editor, I’ve received quite a bit of good (and bad) savings advice over the years. The bad? Anything that requires me to cut out a daily coffee. (Yes, I know my $4-a-day Starbucks...
Wall Street unanimously agrees that next year’s S&P 500 index performance will come nowhere near 2019’s
Stocks and bonds, domestic and international—all have posted nicely positive returns, along with real estate investment trusts and precious metals. Real assets, such as commodities and energy-related master limited partnerships, have been among the few downers. A 60/40 mix of the (ticker: SPY) and (AGG)—exchange-traded funds that track the most widely used benchmarks for the U.S. equity and fixed-income markets—have returned 19.20% for the year, through Wednesday, according to (MORN) That’s the sort of showing that would please most equity-only investors in a typical year, although putting all your chips in the SPDR ETF would have generated a 26.36% return.
The provider of fertility benefits solutions cleared an IPO base Friday with a 29.39 buy point. After a soft start Thursday, shares reversed higher after reporting another quarter of strong sales growth.
AMD's share value is up 1,330% since Lisa Su took over as president and CEO in late 2014. Now, a chip shortage at rival Intel is providing more opportunity for growth. So why are some Wall Street analysts down on AMD's stock market prospects?
We are now in the last month of the decade, one which has seen the market rally to unprecedented heights. This year in particular, the S&P 500 has soared beyond expectations, and is on its way to its biggest yearly gain since 2013. The question on investors' minds is whether 2020 will see a continuation of the trend. Like anything else, when it comes to investing, there are no certainties, but we can try and mitigate the fear of the unknown by using the best tools at hand.TipRanks' Smart Score tool displays the "best stocks to buy" by collecting data from 8 key metrics and using the results to score the stocks accordingly - from 1, at the bottom, all the way up to a “perfect 10,” at the top.So, heading into the new decade we zoomed in on 3 stocks which apart from displaying Strong Buy status also rank up the higher echelons of the smart score chart. Let’s take a look.Caleres (CAL)The US-China trade war has wreaked havoc on all sorts of industries this year due to increased tariffs. The shoe industry has not been spared, either, as global footwear retailer, Caleres, can attest. The stock has vastly underperformed the market this year, slumping almost 20% overall.The recent third-quarter report was a mixed bag, too. The strong performance from Famous Footwear has contributed to record sales in the quarter, yet the increased tariffs weighed down on EPS, which came in at $0.78, and missed estimates by 5 cents. The company cut back its forecast for F2019 to reflect the impact of new tariffs.Nevertheless, 4-star Wedbush analyst Christopher Svezia is stepping up to call Caleres a buy: "CAL shares trade at a ~37% discount to historic levels, cheap for a stock with momentum building into a de-risked 4Q and another year of sales growth and margin expansion driving +LDD EPS gains for FY20.” The analyst further added, “CAL has significantly improved its op. model by divesting non-core assets and moving distribution towards premium channels while improving efficiencies, leading to higher-margin sales across much of its wholesale platform. There is room to drive more productive sales through speed to market capabilities, international growth, the launch of Veronica Beard in SP20 and more.“To this end, Svezia reiterated an Outperform rating on Caleres stock, along with a price target of $27, implying potential upside of 22% from today's closing price. (To watch Svezia’s track record, click here)Svezia isn't alone in his bullish take on Caleres' potential. The stock's "perfect 10" Smart Score indicates a "Strong Buy" analyst consensus, as well as increased hedge fund activity. (See Caleres’s stock analysis on TipRanks)Huya (HUYA)Talking of China, we move on to Guangzhou, which houses the headquarters of live streaming platform, Huya.The platform’s primary focus is gaming and esports, and in the last quarter alone it organized 110 e-Sports tournaments with over 500m viewers, as well as hosting 38 inhouse organized tournaments. The business is diversifying, though, with reality shows, musical performances, and animated content being added to the platform.The broadening of the company’s remit comes alongside international expansion. Huya currently has 17 million monthly active users outside China and has set its sights on 20 million by the end of the year. A driving force towards reaching this goal is the Huya owned Nimo TV, a Spanish language live streaming platform with markets predominantly in Latin America. There are half a billion Spanish speakers worldwide, a huge market for Nimo TV to tap into.Huya reported 3Q19 results with revenue and earnings ahead of consensus on better-than-anticipated live streaming and gross profit margins, and Jefferies’ Thomas Chong likes what he sees.The analyst opined, “Mid-point of 4Q19 revenue guidance is 5% and 11% ahead of consensus and our estimates… We believe the better-than-expected guidance is due stronger sequential growth in paying users, while the company is heading towards the goal of 150m domestic MAU (monthly active users). We see Huya as demonstrating strong execution in its domestic market with overseas expansion in the long run, thanks to its content diversification and localization strategies.”Accordingly, Chong maintained a Buy rating on the Chinese streamer, and increased his price target from $26.80 to $30. The target implies hefty potential upside of nearly 60%. (To watch Chong’s track record, click here)Huya's "perfect 10" score includes a “Strong Buy” consensus analyst rating alongside encouraging sentiment from bloggers and hedge funds. (See Huya's stock analysis on TipRanks)Zendesk (ZEN)Shares of customer service software maker Zendesk are up roughly 30% year-to-date. But not everything has been so glamorous for the stock, especially in the end of July. A disappointing Q2 report halted the upward curve, after which the share price fell sharply.The recent Q3 report was a mixed bag, too. While revenue grew year-over-year by 36%, there were diminishing returns from EMEA (Europe, the Middle East, and Africa) for the second quarter in a row on account of macro and sales implementation headwinds. Billings growth slowed down as well, dropping to 25% as opposed to 35% in the previous quarter.However, Piper Jaffray’s Brent Bracelin is not concerned, saying, “Despite mixed fundamentals over the last two quarters, we still view ZEN as a strategic cloud asset with a unique offering and customer base that sits squarely in an area where spending could increase materially in 2020.”Zendesk has been adding a set of complementary software products to its support ticketing system and customer service software, and these seem to be hitting the spot. Bracelin added, “Fortunately for ZEN, revenue growth has been resilient within the U.S. region accelerating to 41% vs. 38% last quarter driven by strong adoption of the Zendesk Suite and Duet bundles... Interest in Sunshine is high suggesting an even broader move up market could unfold if this product takes hold next year.”Bracelin assumed coverage on ZEN with an Overweight rating, alongside a price target of $94, which implies about 25% upside from current levels. (To watch Bracelin’s track record, click here)Overall, ZEN has received 10 “buy” and 2 "hold" ratings over the past three months. That, alongside encouraging sentiment from investors, bloggers and hedge funds, contributes to a "perfect 10" Smart Score for ZEN. (See Zendesk’s stock analysis on TipRanks)